Approaches to ventilation in intensive care.
BACKGROUND
Mechanical ventilation is a common and often life-saving intervention in intensive care medicine. About 35% of all patients in intensive care are mechanically ventilated; about 15% of these patients develop a ventilation-associated pneumonia. The goal of ventilation therapy is to lessen the work of respiration and pulmonary gas exchange and thereby maintain or restore an adequate oxygen supply to the body's tissues. Mechanical ventilation can be carried out in many different modes; the avoidance of ventilation-induced lung damage through protective ventilation strategies is currently a major focus of clinical interest.


METHODS
This review is based on pertinent articles retrieved by a selective literature search.


RESULTS
Compared to conventional lung-protecting modes of mechanical ventilation, the modern modes of ventilation presented here are further developments that optimize lung protection while improving pulmonary function and the synchrony of the patient with the ventilator. In high-frequency ventilation, tidal volumes of 1-2 mL/kgBW (body weight) are given, at a respiratory rate of up to 12 Hz. Assisted forms of spontaneous respiration are also in use, such as proportional assist ventilation (PAV), neurally adjusted ventilatory assist (NAVA), and variable pressure-support ventilation. Computer-guided closed-loop ventilation systems enable automated ventilation; according to a recent meta-analysis, they shorten weaning times by 32% .


CONCLUSIONS
The currently available scientific evidence with respect to clinically relevant endpoints is inadequate for all of these newer modes of ventilation. It appears, however, that they can lower both the invasiveness and the duration of mechanical ventilation, and thus improve the care of patients who need ventilation. Randomized trials with clinically relevant endpoints must be carried out before any final judgments can be made.
Department of Anesthesiology and Intensive Care, University Hospital Carl Gustav Carus, Dresden.
Peter M
PM
Spieth
Thea
T
Koch
Marcelo
M
Gama de Abreu
D003422:Critical Care / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D011014:Pneumonia / Q000209:etiology* / Q000517:prevention & control*; D012121:Respiration, Artificial / Q000009:adverse effects* / Q000379:methods*; D012131:Respiratory Insufficiency / Q000150:complications / Q000517:prevention & control*; D013813:Therapy, Computer-Assisted / Q000379:methods*; D016896:Treatment Outcome